PDB Short entry for 4BDH HEADER TRANSFERASE 05-OCT-12 4BDH TITLE FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR BINDING TITLE 2 TO CHECKPOINT KINASE 2 (CHK2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 210-531; COMPND 5 SYNONYM: CHK2 CHECKPOINT HOMOLOG, CDS1 HOMOLOG, HUCDS1, HCDS1, COMPND 6 CHECKPOINT KINASE 2; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA2 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PTHREE-E KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.C.SILVA-SANTISTEBAN,I.M.WESTWOOD,K.BOXALL,N.BROWN,S.PEACOCK, AUTHOR 2 C.MCANDREW,E.BARRIE,M.RICHARDS,A.MIRZA,A.W.OLIVER,R.BURKE,S.HOELDER, AUTHOR 3 K.JONES,G.W.AHERNE,J.BLAGG,I.COLLINS,M.D.GARRETT,R.L.M.VAN MONTFORT REVDAT 2 20-DEC-23 4BDH 1 REMARK REVDAT 1 26-JUN-13 4BDH 0 JRNL AUTH M.C.SILVA-SANTISTEBAN,I.M.WESTWOOD,K.BOXALL,N.BROWN, JRNL AUTH 2 S.PEACOCK,C.MCANDREW,E.BARRIE,M.RICHARDS,A.MIRZA,A.W.OLIVER, JRNL AUTH 3 R.BURKE,S.HOELDER,K.JONES,G.W.AHERNE,J.BLAGG,I.COLLINS, JRNL AUTH 4 M.D.GARRETT,R.L.VAN MONTFORT JRNL TITL FRAGMENT-BASED SCREENING MAPS INHIBITOR INTERACTIONS IN THE JRNL TITL 2 ATP-BINDING SITE OF CHECKPOINT KINASE 2. JRNL REF PLOS ONE V. 8 65689 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 23776527 JRNL DOI 10.1371/JOURNAL.PONE.0065689 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.07 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 12558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 618 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.96 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2970 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2003 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2814 REMARK 3 BIN R VALUE (WORKING SET) : 0.1968 REMARK 3 BIN FREE R VALUE : 0.2649 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.25 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2172 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 65 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 82.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.07750 REMARK 3 B22 (A**2) : 3.07750 REMARK 3 B33 (A**2) : -6.15500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.337 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.397 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.257 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.385 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.258 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2240 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3034 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 756 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 47 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 333 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2240 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 302 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2586 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.59 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -25.3622 29.4495 10.3832 REMARK 3 T TENSOR REMARK 3 T11: -0.0733 T22: -0.1701 REMARK 3 T33: -0.1844 T12: -0.0317 REMARK 3 T13: 0.0456 T23: -0.0198 REMARK 3 L TENSOR REMARK 3 L11: 2.3797 L22: 1.2531 REMARK 3 L33: 1.7147 L12: -1.1927 REMARK 3 L13: 0.7785 L23: -1.1280 REMARK 3 S TENSOR REMARK 3 S11: -0.1047 S12: 0.1594 S13: -0.1878 REMARK 3 S21: -0.3049 S22: 0.0294 S23: 0.1306 REMARK 3 S31: 0.0557 S32: -0.1160 S33: 0.0752 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4BDH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054370. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97960 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12574 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 60.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WTJ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% REMARK 280 (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.97333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.98667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.98667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 61.97333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 61.97333 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 203 REMARK 465 PRO A 204 REMARK 465 LEU A 205 REMARK 465 GLY A 206 REMARK 465 SER A 207 REMARK 465 HIS A 208 REMARK 465 MET A 209 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 GLY A 229 REMARK 465 ALA A 230 REMARK 465 CYS A 231 REMARK 465 GLY A 232 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 ALA A 267 REMARK 465 LEU A 268 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 465 GLU A 531 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 210 OG REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 LYS A 241 CE NZ REMARK 470 LYS A 249 CD CE NZ REMARK 470 SER A 252 OG REMARK 470 LYS A 253 CE NZ REMARK 470 GLU A 271 CG CD OE1 OE2 REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 LYS A 278 CE NZ REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 LYS A 289 NZ REMARK 470 LYS A 312 NZ REMARK 470 ASN A 316 CG OD1 ND2 REMARK 470 GLN A 358 CD OE1 NE2 REMARK 470 GLU A 360 CG CD OE1 OE2 REMARK 470 LYS A 373 CE NZ REMARK 470 SER A 379 OG REMARK 470 ARG A 382 CG CD NE CZ NH1 NH2 REMARK 470 THR A 387 OG1 CG2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 470 THR A 432 OG1 CG2 REMARK 470 GLN A 433 CG CD OE1 NE2 REMARK 470 LYS A 444 CD CE NZ REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 470 LYS A 458 CE NZ REMARK 470 GLU A 489 CG CD OE1 OE2 REMARK 470 LYS A 494 CD CE NZ REMARK 470 GLU A 501 CG CD OE1 OE2 REMARK 470 GLU A 502 CD OE1 OE2 REMARK 470 GLU A 504 CG CD OE1 OE2 REMARK 470 SER A 505 OG REMARK 470 THR A 506 OG1 CG2 REMARK 470 LEU A 508 CD1 CD2 REMARK 470 LEU A 512 CG CD1 CD2 REMARK 470 ALA A 513 CA C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 224 148.09 -39.96 REMARK 500 ALA A 294 -141.15 -125.54 REMARK 500 ASN A 316 19.33 59.74 REMARK 500 ARG A 346 -7.17 72.37 REMARK 500 ASP A 347 45.90 -141.05 REMARK 500 ASP A 368 74.06 66.95 REMARK 500 LEU A 467 46.27 -88.78 REMARK 500 ALA A 507 107.15 -42.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 1513 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WVI A 1514 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1515 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1516 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1517 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1518 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555 , A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 2WTC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XBJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XK9 RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 (CHK2) IN COMPLEX WITH REMARK 900 INHIBITOR PV1533 REMARK 900 RELATED ID: 2XM8 RELATED DB: PDB REMARK 900 CO-CRYSTAL STRUCTURE OF A SMALL MOLECULE INHIBITOR BOUND TO THE REMARK 900 KINASE DOMAIN OF CHK2 REMARK 900 RELATED ID: 2XM9 RELATED DB: PDB REMARK 900 STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF REMARK 900 CHK2 REMARK 900 RELATED ID: 2YCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1531 REMARK 900 RELATED ID: 2YCQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV1115 REMARK 900 RELATED ID: 2YCR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH INHIBITOR REMARK 900 PV976 REMARK 900 RELATED ID: 2YCS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV788 REMARK 900 RELATED ID: 2YIQ RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH REMARK 900 INHIBITOR PV1322 REMARK 900 RELATED ID: 2YIR RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH REMARK 900 INHIBITOR PV1352 REMARK 900 RELATED ID: 2YIT RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF CHECKPOINT KINASE 2 IN COMPLEX WITH PV1162, REMARK 900 A NOVEL INHIBITOR REMARK 900 RELATED ID: 4A9R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE REMARK 900 CARBOXAMIDE INHIBITOR REMARK 900 RELATED ID: 4A9S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE REMARK 900 CARBOXAMIDE INHIBITOR REMARK 900 RELATED ID: 4A9T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE REMARK 900 CARBOXAMIDE INHIBITOR REMARK 900 RELATED ID: 4A9U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE REMARK 900 CARBOXAMIDE INHIBITOR REMARK 900 RELATED ID: 4BDA RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDB RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDC RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDD RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDE RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDF RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDG RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDI RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDJ RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) REMARK 900 RELATED ID: 4BDK RELATED DB: PDB REMARK 900 FRAGMENT-BASED SCREENING IDENTIFIES A NEW AREA FOR INHIBITOR REMARK 900 BINDING TO CHECKPOINT KINASE 2 (CHK2) DBREF 4BDH A 210 531 UNP O96017 CHK2_HUMAN 210 531 SEQADV 4BDH GLY A 203 UNP O96017 EXPRESSION TAG SEQADV 4BDH PRO A 204 UNP O96017 EXPRESSION TAG SEQADV 4BDH LEU A 205 UNP O96017 EXPRESSION TAG SEQADV 4BDH GLY A 206 UNP O96017 EXPRESSION TAG SEQADV 4BDH SER A 207 UNP O96017 EXPRESSION TAG SEQADV 4BDH HIS A 208 UNP O96017 EXPRESSION TAG SEQADV 4BDH MET A 209 UNP O96017 EXPRESSION TAG SEQRES 1 A 329 GLY PRO LEU GLY SER HIS MET SER VAL TYR PRO LYS ALA SEQRES 2 A 329 LEU ARG ASP GLU TYR ILE MET SER LYS THR LEU GLY SER SEQRES 3 A 329 GLY ALA CYS GLY GLU VAL LYS LEU ALA PHE GLU ARG LYS SEQRES 4 A 329 THR CYS LYS LYS VAL ALA ILE LYS ILE ILE SER LYS ARG SEQRES 5 A 329 LYS PHE ALA ILE GLY SER ALA ARG GLU ALA ASP PRO ALA SEQRES 6 A 329 LEU ASN VAL GLU THR GLU ILE GLU ILE LEU LYS LYS LEU SEQRES 7 A 329 ASN HIS PRO CYS ILE ILE LYS ILE LYS ASN PHE PHE ASP SEQRES 8 A 329 ALA GLU ASP TYR TYR ILE VAL LEU GLU LEU MET GLU GLY SEQRES 9 A 329 GLY GLU LEU PHE ASP LYS VAL VAL GLY ASN LYS ARG LEU SEQRES 10 A 329 LYS GLU ALA THR CYS LYS LEU TYR PHE TYR GLN MET LEU SEQRES 11 A 329 LEU ALA VAL GLN TYR LEU HIS GLU ASN GLY ILE ILE HIS SEQRES 12 A 329 ARG ASP LEU LYS PRO GLU ASN VAL LEU LEU SER SER GLN SEQRES 13 A 329 GLU GLU ASP CYS LEU ILE LYS ILE THR ASP PHE GLY HIS SEQRES 14 A 329 SER LYS ILE LEU GLY GLU THR SER LEU MET ARG THR LEU SEQRES 15 A 329 CYS GLY THR PRO THR TYR LEU ALA PRO GLU VAL LEU VAL SEQRES 16 A 329 SER VAL GLY THR ALA GLY TYR ASN ARG ALA VAL ASP CYS SEQRES 17 A 329 TRP SER LEU GLY VAL ILE LEU PHE ILE CYS LEU SER GLY SEQRES 18 A 329 TYR PRO PRO PHE SER GLU HIS ARG THR GLN VAL SER LEU SEQRES 19 A 329 LYS ASP GLN ILE THR SER GLY LYS TYR ASN PHE ILE PRO SEQRES 20 A 329 GLU VAL TRP ALA GLU VAL SER GLU LYS ALA LEU ASP LEU SEQRES 21 A 329 VAL LYS LYS LEU LEU VAL VAL ASP PRO LYS ALA ARG PHE SEQRES 22 A 329 THR THR GLU GLU ALA LEU ARG HIS PRO TRP LEU GLN ASP SEQRES 23 A 329 GLU ASP MET LYS ARG LYS PHE GLN ASP LEU LEU SER GLU SEQRES 24 A 329 GLU ASN GLU SER THR ALA LEU PRO GLN VAL LEU ALA GLN SEQRES 25 A 329 PRO SER THR SER ARG LYS ARG PRO ARG GLU GLY GLU ALA SEQRES 26 A 329 GLU GLY ALA GLU HET NO3 A1513 4 HET WVI A1514 12 HET EDO A1515 4 HET EDO A1516 4 HET CL A1517 1 HET EDO A1518 4 HETNAM NO3 NITRATE ION HETNAM WVI 3-METHYL-4-(THIOPHEN-2-YL)-1H-PYRAZOL-5-AMINE HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 2 NO3 N O3 1- FORMUL 3 WVI C8 H9 N3 S FORMUL 4 EDO 3(C2 H6 O2) FORMUL 6 CL CL 1- FORMUL 8 HOH *65(H2 O) HELIX 1 1 PRO A 213 GLU A 219 1 7 HELIX 2 2 ASN A 269 LEU A 280 1 12 HELIX 3 3 LEU A 309 VAL A 314 1 6 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 LYS A 349 GLU A 351 5 3 HELIX 6 6 THR A 378 GLY A 386 1 9 HELIX 7 7 ALA A 392 SER A 398 1 7 HELIX 8 8 ARG A 406 GLY A 423 1 18 HELIX 9 9 SER A 435 GLY A 443 1 9 HELIX 10 10 ILE A 448 ALA A 453 1 6 HELIX 11 11 SER A 456 LEU A 467 1 12 HELIX 12 12 THR A 476 ARG A 482 1 7 HELIX 13 13 HIS A 483 GLN A 487 5 5 HELIX 14 14 ASP A 488 GLU A 504 1 17 SHEET 1 AA 5 TYR A 220 THR A 225 0 SHEET 2 AA 5 VAL A 234 GLU A 239 -1 O LEU A 236 N SER A 223 SHEET 3 AA 5 LYS A 245 SER A 252 -1 O VAL A 246 N ALA A 237 SHEET 4 AA 5 ASP A 296 LEU A 301 -1 O TYR A 297 N ILE A 251 SHEET 5 AA 5 ILE A 288 ASP A 293 -1 N LYS A 289 O VAL A 300 SHEET 1 AB 3 GLY A 307 GLU A 308 0 SHEET 2 AB 3 VAL A 353 LEU A 355 -1 N LEU A 355 O GLY A 307 SHEET 3 AB 3 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SHEET 1 AC 2 ILE A 343 ILE A 344 0 SHEET 2 AC 2 LYS A 373 ILE A 374 -1 O LYS A 373 N ILE A 344 SITE 1 AC1 4 LEU A 375 GLY A 403 ASN A 405 ARG A 406 SITE 1 AC2 6 ALA A 247 LEU A 301 GLU A 302 MET A 304 SITE 2 AC2 6 GLU A 308 LEU A 354 SITE 1 AC3 4 GLU A 219 ASN A 290 PHE A 291 PHE A 292 SITE 1 AC4 5 GLU A 273 LEU A 277 THR A 367 ASP A 368 SITE 2 AC4 5 PHE A 369 SITE 1 AC5 3 VAL A 211 TYR A 212 ARG A 406 SITE 1 AC6 2 ARG A 346 ASN A 405 CRYST1 91.080 91.080 92.960 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010979 0.006339 0.000000 0.00000 SCALE2 0.000000 0.012678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010757 0.00000